Close Menu

NEW YORK (GenomeWeb) – DNA Script announced today that it has acquired an exclusive license from Dynamic Combinatorial Chemistry (DCC) to a novel DNA building block for use in enzymatic DNA synthesis.

The building blocks, which were initially developed by DCC affiliate Firebird Biomolecular Sciences, are reversible terminator nucleotides with cleavable protective groups that help in controlling the enzymatic synthesis process, according to DNA Script COO Sylvain Gariel.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.